Your session is about to expire
← Back to Search
Behavioural Intervention
TMS for ADHD
N/A
Recruiting
Led By Steve W Wu, M.D.
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 12-17 years
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after each itbs train
Summary
This trial will use Transcranial Magnetic Stimulation (TMS) to study how stimulating a specific area in the brain, the pre-supplementary motor area (pre-SMA), affects inhibitory control
Who is the study for?
This trial is for children aged 12-17 with ADHD. Participants can be on stimulants, but must stop them 24 hours before and during TMS visits.
What is being tested?
The study tests if Transcranial Magnetic Stimulation (TMS) targeting the pre-SMA brain area affects self-control in ADHD patients. It compares active TMS to a sham (fake) treatment.
What are the potential side effects?
TMS may cause discomfort at the stimulation site, headache, lightheadedness, or seizures in very rare cases.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 12 and 17 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after each itbs train
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after each itbs train
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
EEG-based alpha activity
EEG-based beta activity
TMS-based Cortical Silent Period (cSP)
+1 moreSecondary study objectives
Stop Signal Reaction Time
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active repetitive TMSActive Control1 Intervention
Group II: Sham repetitive TMSPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
837 Previous Clinical Trials
6,565,297 Total Patients Enrolled
33 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
4,033 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Steve W Wu, M.D.Principal InvestigatorChildren's Hospital Medical Center, Cincinnati
Share this study with friends
Copy Link
Messenger